LenSx Laser System. Indicated for use in patients undergoing cataract surgery and refractive sur...

FDA Device Recall #Z-1688-2016 — Class II — April 14, 2016

Recall Summary

Recall Number Z-1688-2016
Classification Class II — Moderate risk
Date Initiated April 14, 2016
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Alcon Research, Ltd.
Location Fort Worth, TX
Product Type Devices
Quantity 81 units

Product Description

LenSx Laser System. Indicated for use in patients undergoing cataract surgery and refractive surgery.

Reason for Recall

Alcon is conducting a voluntary recall of all LenSx Lasers with Corneal Flap Capability after receiving reports concerning incomplete corneal flap creation, which manifests as an un-dissected area(s) within the side cut.

Distribution Pattern

United States, Albania, Australia, Brazil, Chile, Costa Rica, Czech Republic, France, Germany, Greece, Hungary, India, Italy, Romania, Slovakia, Spain, Taiwan, Thailand, Turkey, UAE, Ukraine

Lot / Code Information

Serial Numbers: 0511-A013 0313-A345 0713-A455 0415-A019 0912-A258 0313-A359 1213-A613 0412-A142 0412-A137 1114-A943 0212-A112 0313-A357 0813-A469 1113-A605 0314-A697 0315-A981 0913-A530 1012-A286 0515-A037 1112-A291 0515-A042 1011-A065 1012-A284 1013-A555 1211-A086 1012-A287 0912-A245 0614-A783 1113-A596 1014-A916 1011-A062 0615-A044 0913-A506 0313-A353 0615-A050 0615-A056 0912-A247 1114-A938 0712-A202 0714-A824 0113-A320 0212-A117 0614-A782 0614-A784 1112-A294 0712-A201 0514-A749 0715-A071 1111-A067 1214-A948 1013-A542 0314-A687 1213-A614 0215-A976 0312-A135 1012-A285 1013-A548 0215-A978 0412-A139 1113-A586 0312-A129 1011-A050 1213-A612 0314-A685 1112-A292 1012-A264 1015-A126 1111-A077 1013-A547 1114-A931 0112-A099 0112-A101 0413-A372 0413-A380 0512-A157 0612-A200 0715-A073 0811-A034 0815-A097 1013-A554 1113-A587

Other Recalls from Alcon Research, Ltd.

Recall # Classification Product Date
Z-2408-2023 Class II Infinity FMS Pak Jun 28, 2023
Z-2407-2023 Class II Centurion FMS Pak Jun 28, 2023
Z-2406-2023 Class II Constellation Procedure Pak Jun 28, 2023
Z-2410-2023 Class II Phaco Standalone Tips Jun 28, 2023
Z-2411-2023 Class II Alcon Custom Pak Jun 28, 2023

Frequently Asked Questions

Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.